Tiny-people mushrooms are not a joke: they expose how the brain sizes up the world

Why would the brain, given a free pass to invent anything, invent tiny people who respect the laws of physics? That question is more interesting than the punchline, and it is the reason we think the "mushroom that makes you see elves" story deserves to be taken seriously.

The facts first. Researchers at the University of Utah used DNA sequencing to link so-called Lilliputian hallucinations in Southwest China and the northern Philippines to one species, Lanmaoa asiatica, according to the university's own account of a study published in Mycologia on June 5, 2026. The team found none of the known psychoactive mushroom compounds, psilocybin included. Reports from Papua New Guinea go back to 1934, but no specimens could be collected there for comparison, so that link remains unverified.

The most interesting part is how well-behaved the hallucinations are

Classic psychedelics tend to give you shifting patterns and warped geometry, and the content varies by person and mindset. This mushroom does something else. People report dozens or hundreds of figures, roughly 3 to 30 centimeters tall, in vivid detail, and about 90% describe elf-like or clown-like characters in colorful clothes. Crucially, they don't float through walls: they walk around obstacles and fall off table edges. One account has them jumping off a spoon into a bowl of soup.

That is the scientifically juicy bit. A hallucination that is anchored in the room, obeys gravity and is the wrong size looks like a failure in the brain's scale-and-presence machinery, not a random flood of imagery. We would not go further than that, because nobody knows the mechanism. But the contrast is useful: the brain seems to keep its model of the room intact and mis-set one parameter, the size of the occupants. If that reading holds, it suggests perception works as a set of separable settings rather than one seamless picture.

Field reports were dismissed too quickly, and that is the real lesson

In the 1960s, samples from Papua New Guinea reached Albert Hofmann, who found nothing. The conclusion was that the stories were cultural drama, and research largely stopped. A negative chemistry result became a verdict on the witnesses. In our view that was the mistake. Three cultures describing a very specific vision, and DNA tying two of them to one species, is hard to explain as coincidence. Local knowledge was ahead of the lab: as the BBC reported, a Yunnan restaurant sets a 15-minute timer so diners don't eat the mushroom too soon.

The moral for researchers is humbling. When villagers, cooks and hospitals agree on something for decades, "we found nothing" more likely means "we didn't look in the right place."

The excitement needs a leash, because the key compound is still a blank

Restraint is warranted. The unknown compound has not been isolated; that is the team's stated next step. The mouse work described by the BBC was research still being prepared for publication, so it is not yet established. And nothing here is a treatment. The mushroom is also no harmless novelty: the BBC says a Yunnan hospital treats hundreds of cases a year, and BBC Wildlife Magazine notes episodes of one to three days, with delirium and dizziness in some cases.

There is also a temptation to turn this into philosophy. A Psychology Today column argues the episode blurs "subjective error" and "objective reality". We think that is overreaching. Independent people seeing the same thing is better explained by one chemical hitting one shared piece of human wiring than by any crisis of reality.

Don't laugh, don't try it, and fund the chemistry

Lilliputian hallucinations also occur in alcohol withdrawal, dementia and macular degeneration, yet they are rare there, so a reliable trigger would be a lab tool no clinic can offer. Isolating the compound is the priority, and we think the funding case is strong. The tiny people are a symptom of something the brain does all the time, which is deciding how big and how real things are.